Calliditas Therapeutics AB (CALT)
40.00
0.00 (0.00%)
USD |
NASDAQ |
Sep 27, 16:00
Calliditas Therapeutics Shareholders Equity (Quarterly): 10.06M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 10.06M |
| March 31, 2024 | 11.28M |
| December 31, 2023 | 33.26M |
| September 30, 2023 | 32.29M |
| June 30, 2023 | 46.45M |
| December 31, 2022 | 73.52M |
| September 30, 2022 | 65.18M |
| June 30, 2022 | 70.57M |
| March 31, 2022 | 94.32M |
| December 31, 2021 | 111.45M |
| September 30, 2021 | 143.50M |
| June 30, 2021 | 110.10M |
| March 31, 2021 | 125.64M |
| Date | Value |
|---|---|
| December 31, 2020 | 147.82M |
| September 30, 2020 | 153.56M |
| June 30, 2020 | 152.86M |
| March 31, 2020 | 72.26M |
| December 31, 2019 | 84.33M |
| September 30, 2019 | 82.80M |
| June 30, 2019 | 71.11M |
| March 31, 2019 | 61.93M |
| December 31, 2018 | 68.84M |
| September 30, 2018 | 74.23M |
| June 30, 2018 | 0.8118M |
| March 31, 2018 | 2.991M |
| December 31, 2017 | 4.057M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
10.06M
Minimum
Jun 2024
153.56M
Maximum
Sep 2020
85.47M
Average
78.93M
Median
Shareholders Equity (Quarterly) Benchmarks
| Abliva AB | 6.352M |
| NuCana PLC | 4.806M |
| Karolinska Development AB | 115.99M |
| Oncopeptides AB | 12.22M |
| TC BioPharm (Holdings) PLC | 1.364M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 164.63M |
| Total Liabilities (Quarterly) | 154.56M |
| Debt to Equity Ratio | 9.200 |
| Current Ratio | 2.686 |
| Net Debt Paydown Yield | -1.76% |